OraSure Technologies develops, manufactures and markets point-of-care diagnostic products, oral fluid specimen collection devices that leverage proprietary oral fluid technologies, laboratory diagnostic products, including immunoassays and other in vitro diagnostic tests, and other medical devices.
Our product line includes infectious disease tests for the detection of antibodies for the HIV virus (OraQuick® In-Home HIV Test and OraQuick ADVANCE® Rapid HIV-1/2 Antibody Test), antibodies for Hepatitis C virus (OraQuick® HCV Rapid Antibody Test) and antigens for influenza type A and type B (OraSure QuickFlu™) as well as the OraSure® HIV-1 Oral Specimen Collection Device. We also sell oral fluid testing solutions for drugs of abuse testing, including Intercept® Oral Fluid Drug Testing System and Q.E.D.® Saliva Alcohol Test. Additionally, the Company manufactures and sells several leading products for the cryosurgical removal of common and plantar warts and several other benign skin lesions.
The information provided on this website is intended only for the residents of the United States and/or of the European Union. The products discussed herein may have different labeling in different countries and may not be for sale in all other countries.